IPO registrations (S-1, F-1) · Registrants

Aptevo Therapeutics Inc.

SEC CIK

1671584 · filings on EDGAR ↗

Registration

Form S-1, first filed 2023-06-30, last 2026-08-21; 11 initial registrations, 9 amendments

Outcome

Final prospectus filed 2023-08-03; declared effective 2023-08-01; withdrawal requested 2025-05-13

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

2401 4TH AVE., SUITE 1050, Seattle, WA 98121

EIN

81-1567056

Ticker

APVO (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Aptevo Therapeutics Inc. on the corporate pages

On this site

• Business registration: APTEVO THERAPEUTICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: APTEVO THERAPEUTIC, INC. EXACT (EIN (EXACT))
• Form D issuer: Aptevo Therapeutics Inc. EXACT (CIK (EXACT))
• SEC filer: Aptevo Therapeutics Inc. EXACT (CIK (EXACT))

Filings 48

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.